 |
||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
  |
||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||
 |
Archive for the ‘Medical Marijuana Stocks’ Category
Media Advisory: “The Birth of a New Industry!”
TORONTO, June 3, 2014 /CNW/ –
| WHAT: | A First for Toronto! The Purpose of this Press Conference is to advise the MEDIA about GreenRush Financial Investment Conferences. |
| WHO: | The Press Conference is hosted by Next Gen and its wholly owned subsidiary, GreenRush Financial Conferences, The Canadian Securities Exchange and Jacob Securities Inc. |
| WHEN: | June 5, 2014, 4:15 P.M. |
| WHERE: | Rideout Room, Third Floor, Toronto Region Board of Trade First Canada Place, 77 Adelaide Street, Toronto, Ontario |
| WHY: | The Hosts of the Press Conference share a similar vision: specifically they believe in the need to provide a forum for Education, Venture Capital, Investment, Finance, Business to Business Opportunities, as well as to act as facilitators for these emerging industries. |
About GreenRush Financial Conferences
Companies seeking financing for their projects (business to business) will utilize the GreenRush Financial Conference as their platform to Educate Institutional Investors, Financial Advisors, Accredited and Retail Investors and the general public about their projects, their companies, and related business plans. The Toronto conference will be held on June 26, 2014 at the Metro Toronto Convention Centre, North Institution Hall. On May 7, 2014, GreenRush completed its inaugural sold out Vancouver conference with over 1200 attendees, 40 exhibitors, and 28 industry speakers from across North America. Media coverage was received from major outlets across Canada and the United States. (Click HERE for further details)
SOURCE Next Gen Metals Inc.
Taylor Duncan-Barr, [email protected], 604 648.1405; Ray Rich, [email protected], 604 648.1401; Rob Cook, [email protected], 1.416.367.7349; Khurram Malick, [email protected], 1.416.866.8314; Website: nextgenmetalsinc.com, greenrushfinancialconferences.com, www.thecse.ca, www.jacobsecurities.comCopyright CNW Group 2014
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
US House of Representatives Votes to Stop Medical Marijuana Raids
Saved under Congress, Marijuana, Scott Gaudinier, U.S.
Tags: marijuana
Medical marijuana, experiencing a huge spark with a recent outcry of public support across the United States, has now spread to members of Congress, as the U.S. House of Representatives votes to stop federal raids on those who use medical marijuana. Last Thursday evening the House passed an amendment that would prevent the Drug Enforcement Administration (DEA) from pursuing individuals and patients in states where medical use of the drug is legal.
Coming as a pleasant surprise to many citizens across the U.S., the House’s decision reached across party lines, with both Democrats and Republicans showing their support of the amendment with their votes. In a 219 to 189 decision the amendment, led by California Democratic Representative Sam Farr and California Republican Dana Rohrabacher, is the first amendment of its kind to succeed in the House of Representatives.
While the amendment was able to pass mainly due to vast support from Democratic members of the House, there was an observable majority of Republican votes cast in support of the said measure. For this to have happened, the amendment had already been previously backed by a group of co-sponsors from the two opposing parties.
The issue faced in the decision to stop medical marijuana raids was the fact that there was a “routine spending bill†which had been already in place. This allowed for federal tax dollars to be awarded to various government agencies, especially the Justice Department. In turn, the Justice Department has continued its raids of medical marijuana facilities in states across the country where medicinal sales are allowed and adhere to legal terms. However, the new amendment recently passed by the House hopes to prevent federal agencies from continuing these raids henceforth.
Director of Federal Policies at the Marijuana Policy Project Dan Riffle stated that Congress and the overall federal government have begun their shift toward “a more sensible policy†regarding pot, facing strong public pressure. He also made the statement that this vote is historically important after years of the government-initiated “war on drugs†during Ronald Reagan’s years in the White House.
While some critics have made their case that the amendment would only increase the misuse of an “addictive drug†and prevent the DEA from spotting illegal street dealers, House Republican Andy Harris stated in response how other drugs that are addictive have not been advertised as having positive medical benefits.
Unlike marijuana, which many health experts agree has improved patients’ general health, legal substances like nicotine and tobacco cause cancer and have not showed any positive medicinal benefits in any instance. As Harris said, “Nobody writes a prescription and says ‘Smoke a couple of cigarettes and cure your epilepsy.’â€
As the U.S. House of Representatives votes to stop medical marijuana raids in the future through the passing of this new amendment, it faces other obstacles as it still needs approval from both the Senate and President Barack Obama. Yet many people across the country, including advocates, patients, doctors, average citizens, and an increasing number of politicians, remain steadfast in their hopes of a nearing reality of both the ultimate decriminalization and legalization of marijuana in the U.S.
By Scott Gaudinier
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Lexaria and Enertopia Update LOI with Signed Definitive Joint Venture Agreement
Kelowna, BC / May 29, 2014 / Lexaria Corp. (LXRP-OTCQB) (LXX-CSE) (the “Company” or “Lexaria”) announces it has signed the definitive Joint Venture agreement as required in the Letter of Intent that was first announced with Enertopia Corp on April 10, 2014.
The Definitive Joint Venture agreement was contemplated at the time of signing the initial April 10, 2014 Letter of Intent, and governs the procedures and practices by which the marijuana production facility in the Greater Toronto Area will be operated. As previously reported, Lexaria is paying 55% of costs in order to earn a 49% interest in the facility.
The municipal approval process continues to proceed for this facility, located in the Greater Toronto Area. Neither the LOI nor the Definitive Agreement has any bearing or relationship with the newer Eastern Ontario proposed facility announced on May 27, which itself will be owned and operated 100% by Lexaria.
Separately, the Company announces that 50,000 stock options priced at $0.10 have been exercised and Lexaria has received $5,000 in payment.
About Lexaria
Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.
To learn more about Lexaria Corp. visit http://www.lexariaenergy.com/
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Inquiries: (647) 519-2646
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria, and no assurance that any proposed new facility will be built or proceed, nor that municipal or Health Canada regulatory approvals will be obtained. There is no assurance that the municipality where the building is located will grant its approval for a medical marijuana production facility.
The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Enertopia and Lexaria Update LOI with Signed Definitive Joint Venture Agreement
Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce it has signed the definitive Joint Venture agreement as required in the Letter of Intent that was announced with Lexaria Corp on April 10, 2014.
The Definitive Joint Venture agreement was contemplated at the time of signing the initial April 10, 2014 agreement, and governs the procedures and practices by which the marijuana production facility in the Greater Toronto Area will be operated. As previously reported, Enertopia is paying 45% of costs in order to earn a 51% interest in the facility. The municipal approval process continues to proceed for this facility, located in the Greater Toronto Area
The Company also announces that 200,000 warrants have been exercised raising $20,000 in net proceeds.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
About Enertopia
Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that Lexaria Corp will conclude any Definitive Agreements. Similarly, there can be no assurance that the Company will be successful in attracting key people.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
INTERVIEW – Lexaria Corp. Goes “Beyond The Press Release” to discuss the company’s second production facility and vendor intention to finance up to $3,000,000
Lexaria is one of the most advanced and fastest growing companies within the exploding medical Marijuana Industry, one of the most recession-proof industry sectors without any apparent boom / bust cycle given North American demographics and the rapidly accelerating acceptance of medical marijuana.
Chris Bunka Chairman, CEO & President Lexaria Corp. Goes “Beyond The Press Release” to discuss the company’s second production facility and vendor intention to finance up to $3,000,000
Hub On AGORACOM / Corporate Website / Listen to Interview
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
InvestmentPitch Media Attending Next Gen’s GreenRush Financial Conference in Toronto, Ontario on June 26, 2014, Covering Medical Marijuana, Industrial Hemp and Alternative Medicines
Vancouver, British Columbia–(May 28, 2014) – InvestmentPitch Media will be attending the upcoming GreenRush Financial Conference June 26, 2014. The conference will be held at the Metro Toronto Convention Centre North Constitution Hall from 7:30 am to 6:00 pm.
For more details, please watch this video. If this link is not enabled, please visit www.InvestmentPitch.com and enter “GreenRush Conference” in the search box. InvestmentPitch is a media sponsor for this event, and will be available to film presentations and conduct interviews.
If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_jednfe2g/InvestmentPitch-Media-would-like-to-invite-you-to-join-us-at-the-upcoming-GreenRush-Financial-Conference
The conference will feature insightful speakers, government officials, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.
The conference will provide a platform for venture capital investment, education and business to business opportunities, with exhibitors having a forum to showcase their products, technologies and services.
For more information, to book a booth, or to register for any of the GreenRush Conferences, please visit the conference’s website www.greenrushfinancialconferences.com or email [email protected].
The GreenRush Financial Conferences are 100% owned by Next Gen Metals Inc. (CSE: N), symbol “N” on the Canadian Securities Exchange. For more information about Next Gen, please visit www.NextGenMetalsInc.com, phone 604-685-1870 or email [email protected].
We hope you’ll join us on June 26th at the GreenRush Financial Conference.
InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports. Please visit InvestmentPitch.com and browse the extensive library of investment videos.
CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
[email protected]
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway: http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
New York Times Investigates Canadian Marijuana Industry
Lexaria Announces Second Production Facility in Ontario
VANCOUVER, British Columbia, May 28, 2014 — On May 24, 2014 the New York Times published a 2,900 word expose on the Canadian medical marijuana industry, centering on a chocolate factory in Smith Falls, Ontario converted to a climate-controlled marijuana plant now operated by Tweed Marijuana, a publicly traded company worth $121 million.
“The Canadian government decided to create an extensive, heavily regulated system for growing and selling marijuana,” explained the New York Times article, “The new rules allow users with prescriptions to buy only from one of the approved, large-scale, profit-seeking producers.”
The Canadian government estimates that within the next decade the marijuana business will generate more than $3.1 billion a year in taxable sales.
On May 27, 2014 Lexaria Corporation (CSE:LXX) (OTCQB:LXRP) announced that it had entered a detailed Letter of Intent for its second marijuana production facility in Eastern Ontario, Canada.
The agricultural growing facility has total potential area of over 80,000 square foot to be completed in a multi-phase development program. Lexaria will be the operator of this facility and owns 100% rights, with no overrides or royalties due to any party.
Other recent successes in the Canadian medical marijuana space are Windfire Capital whose stock price has tripled in the last 12 months and Affinor which has experienced 1000% share price increase after diversifying into medical marijuana and industrial hemp.
Like many of the new marijuana captains, Lexaria President and CEO Chris Bunka is slightly bemused to find himself in the industry.
“I’m 52 years old and I never smoked a joint in my life,” stated Bunka in an exclusive interview with Financial Press, “But I know that I can deploy capital in the medical licensed marijuana business and earn a greater return per dollar than I can in the oil and gas business.”
In 2006 Lexaria discovered an oil field in the state of Mississippi. Over the last three fiscal years, that field has produced about $100,000 a month in revenue.
“The oil field is not large enough to capture the love of the investing public,” admitted Bunka, “but it enabled us to function without doing any harm to existing shareholders.”
Bunka’s plan is to divest Lexaria’s oil assets to fund and focus on the medical marijuana industry – using the same philosophy of first protecting and then growing shareholder value.
“Our first marijuana project is a joint venture which we have a 49% stake in, with Enertopia,” stated Bunka, “Our facility is potentially as large as 75,000 feet – and municipal approval is expected soon.”
Intent that Lexaria control its own destiny, the company acquired 100% interest in a facility in Eastern Ontario.
“The building owner is contributing up to $1 million toward the renovations of the building,” stated Bunka, “In addition they are intending to invest up to $2 million in our recently announced financing, so they will become part-owners of Lexaria.”
Lexaria has not had to issue any shares in order to acquire this newest marijuana facility.
“If Lexaria has difficulties obtaining municipal approval for this building, the property owner will make another facility available in another municipality,” stated Bunka, “Let’s face it, crops are vulnerable to disease, licences occasionally get revoked. To protect shareholder value, it is important not to put all your eggs in one basket. Our intention is to spread the risk over multiple facilities.”
Over the last six years, Bunka has personally invested over $1.5 million in Lexaria. Documents posted on sedar.com confirm that the majority of the shares have been purchased on the open market. There is no record of any shares being sold by Bunka.
The medical marijuana space is heating up but Lexaria’s track record indicates that management is not looking for a quick exit. The company is adapting its business model to a new opportunity, with an eye to rapid growth and risk mitigation.
We anticipate getting approvals from the municipal government in Eastern Ontario as well as the fire department and police,” stated Bunka, “We will hire a consulting group to ensure that the licensing application meets all criteria. Shortly after this we hope to get a “comfort letter” from Health Canada confirming that there are no serious deficiencies in the application – adding another layer of shareholder security.
Lexaria is now involved in two potential marijuana production facilities, both located in Ontario, and each capable of expansion and large enough to offer significant cost efficiencies compared to smaller facilities.
“It’s just so rare that you have an industry that’s growing but which has a huge established market,” stated Tweed CEO Chuck Rifici in the New York Times article.
Most medical users consume 1-3 grams per day. Consuming 1 gram a day at $7.80 per gram is an annual expenditure of $2,847 per customer.
Lexaria is trading at .25 with a market cap of under $8 million.
Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author’s only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.
Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.
CONTACT: 156 Valleyview Road, Kelowna, BC V1X 3M4
p. 250 765 6424
f. 250 765 6414
950, 1130 West Pender Street Vancouver BC V6E 4A4
p. 604 602 1675
f. 604 685 1602
e. [email protected]
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical
Marijuana Stocks Gateway:
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Lexaria Announces Second Production Facility and Vendor Intention to Finance up to $3,000,000
Kelowna, British Columbia–(May 27, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it has entered a detailed Letter of Intent with Huntington Property Group Inc, an Ottawa-based real estate developer for its second marijuana production facility in Canada. As provided for in Letter of Intent, Lexaria also announces a financing intention of up to $3,000,000, including Vendor Financing, subject to certain terms and conditions as detailed in the Letter of Intent.
The facility is located in the Eastern Ontario area and is of a total potential area of over 80,000 sq ft; to be completed in an expected multi-phase development program. The first phase is to be over 20,000 sq ft. Lexaria will be the operator of this facility and would own 100% rights, with no overrides or royalties due to any party. Lexaria is issuing no shares whatsoever in order to acquire the rights to this facility.
No lease (rent) payments are scheduled to begin until such time as the municipality grants its approval of the building zoning for marijuana production purposes. Lexaria and the building owner are preparing an application to the municipality for such approval and based upon available information anticipate that such approval could be granted within 90 days. In the event the municipality does not for any reason approve the building for the purpose of medical marijuana production, Lexaria and the building owner have agreed to locate and use an alternate building.
Alan Whitten, President of Huntington Property Group Inc. says, “We are happy to get involved in this burgeoning sector. We believe in Lexaria’s growth plan and have confidence in their personnel to achieve their plans, and are pleased to commit to it. We look forward to a mutually beneficial long term relationship, as our investment indicates.”
Lexaria notes that this agreement for its second production facility was negotiated and entered only six weeks after its first production facility was announced, which was the 49%-owned joint venture with Enertopia Corp.
Lexaria will own 100% interest in the production facility by paying 100% of all initial and ongoing expenses related to the project. An initial 10-year lease will be entered, with options to renew the lease for an additional 16 years. The vendor is contributing up to $1,000,000 in cash payments directed toward the conversion costs required to renovate for the marijuana production facility, thus reducing Lexaria’s capex in the renovation costs.
Lexaria is also pleased to announce that a number of investors, including the building owner, have agreed in principle and subject to suitability and other conditions, to invest up to $2,000,000 into Lexaria, on terms in accordance with Canadian Securities Exchange and all regulatory requirements including required restricted periods. The intended investment would be part of the financing recently announced by Lexaria, and would be by Canadian accredited, non-US persons. Proceeds from this financing will be used to build out the Eastern Ontario facility for the purposes of medical marijuana production, and for general working capital. Lexaria cautions that the Letter of Intent is a preliminary step only and cannot provide any assurances that the Letter of Intent will result in a successfully closed acquisition or financing.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Chris Bunka commented that “We are very pleased to enter the next phase of our growth initiative with the prestigious Huntington Property Group Inc. We intend to nurture this relationship for the benefit of all our shareholders. We share a common vision, and will also enjoy long term benefits as confirmed by their capital commitment.”
Lexaria believes that all stakeholders, including prospective customers, shareholders and others, are best served by Lexaria operating under more than a single Health Canada license under the MMPR. Multiple licenses protect shareholders and customers by adding redundancy to operations, and avoiding or mitigating loss in the event of unexpected production complications or any other unpredictable events.
Lexaria is now involved in two potential marijuana production facilities, both located in Ontario, each capable of significant expansion from Phase I initial buildout, and each large enough to offer significant cost efficiencies compared to smaller facilities.
The new facility in no way reduces Lexaria’s commitment to its previously announced greater Toronto area facility, which continues to advance separately. The Company looks forward to reporting additional developments on the advancement of this facility as they occur.
About Lexaria
Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.
To learn more about Lexaria Corp. visit www.lexariaenergy.com.
FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Ken Faulkner, Institutional and Business Development: (250) 765-3630 Office
Clark Kent, Media Inquiries: (647) 519-2646
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria, and no assurance that any proposed new facility will be built or proceed, nor that municipal or Health Canada regulatory approvals will be obtained. There is no assurance that the intended $2,000,000 investment by a number of investors, including the building owner, will in fact occur in whole or in part. There is no assurance that the first phase renovation project of approx. 20,000 sq ft will in fact be constructed, or that it will be constructed on time or budget. There is no assurance that the municipality where the building is located will grant its approval for a medical marijuana production facility.
The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks
Next Gen Announces Successful Inaugural GreenRush Financial Conference in Vancouver; Invites Investors and Exhibitors to Attend the Upcoming Toronto Conference
-The Inaugural Vancouver GreenRush Financial Conference exceeded expectations
-Over 1,200 attendees
-Over 35 exhibitors
-Expert speakers from across North America
-Media coverage from the major outlets across Canada
-The second conference is to be held in Toronto, Ontario on June 26, 2014 at the Metro Toronto Convention Centre North in the Constitution Hall
-Further conferences are also slated for Canada, the United States and Europe
-For further information and to register as an attendee please visit our websites at www.greenrushfinancialconferences.com and www.nextgenmetalsinc.com
–GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (CSE-N, OTC-PK NXTTF, FSE-M5BN) and is aligned to be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries
-Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities throughout the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors
Vancouver, British Columbia, Canada / TNW-ACCESSWIRE / May 26, 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce that its inaugural Vancouver GreenRush Financial Conference exceeded expectations. Next Gen also formally invites interested investors, industry participants, stakeholders and exhibitors to our second GreenRush Financial Conference in Toronto, Ontario on June 26, 2014.
Jay Oness, COO, stated that, “We are thrilled with the results of the inaugural Vancouver GreenRush Financial Conference. We would like to thank the 35+ exhibitors, 1200+ attendees and industry expert speakers from around the world that came together to make this conference the success that it was. We look forward to hosting our second GreenRush Financial Conference in Toronto, Ontario on June 26, 2014. We anticipate that the second show will be even bigger and better than the first.”
If you are interested in being a speaker, exhibitor or sponsor for the Toronto Conference please submit your indication of interest as soon as possible to the GreenRush Financial Conference team as it is selling out quickly.
For more information on GreenRush Conferences please visit our website at
www.greenrushfinancialconferences.com, email our Conference Coordinators (see below)
Or contact us by phone at (604) 685-1870
Conference Coordinators
Taylor Duncan-Barr – [email protected]
Ray Rich – [email protected]
Ray Lagace – [email protected]
About Next Gen
(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry.
Next Gen’s vision is to be the leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry.
Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industries. For further information, visit our website at www.nextgenmetalsinc.com.
On March 20, 2014 Next Gen Metals announced that it has established its first wholly owned subsidiary, a Conference Division that intends to host Canada’s first conferences focused on business to business opportunities, investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Financial Conferences’ vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.
On May 6, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories vision is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.
In light of Next Gen’s vision, Management’s intention is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.
In light of Next Gen’s vision, Management is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.
Tel: +1 604 685 1870 Fax: +1 604 685 8045 Website: http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square, West Tower, Vancouver, B.C., Canada, V5Z 3X7
On behalf of the Board of Directors
“Jay Oness”
Jay Oness
COO
FORWARD LOOKING INFORMATION
This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.
Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.
This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
The CSE has neither reviewed nor approved the contents of this News Release.
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks